UNICA IRIS Institutional Research Information System

EFFICACE, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.171
NA - Nord America 1.215
AS - Asia 707
SA - Sud America 83
AF - Africa 27
OC - Oceania 16
Totale 14.219
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.772
US - Stati Uniti d'America 1.181
SG - Singapore 322
CN - Cina 162
SE - Svezia 97
VN - Vietnam 72
DE - Germania 66
FI - Finlandia 62
BR - Brasile 57
UA - Ucraina 36
GB - Regno Unito 31
FR - Francia 29
CA - Canada 25
KR - Corea 25
NL - Olanda 22
HK - Hong Kong 20
AU - Australia 16
BD - Bangladesh 15
IN - India 15
PL - Polonia 14
AT - Austria 13
JP - Giappone 10
ZA - Sudafrica 10
AR - Argentina 9
IQ - Iraq 9
AE - Emirati Arabi Uniti 8
BE - Belgio 7
SA - Arabia Saudita 7
ES - Italia 6
VE - Venezuela 6
MY - Malesia 5
MX - Messico 4
OM - Oman 4
TR - Turchia 4
DZ - Algeria 3
EC - Ecuador 3
EG - Egitto 3
ET - Etiopia 3
IR - Iran 3
PK - Pakistan 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
CL - Cile 2
CR - Costa Rica 2
ID - Indonesia 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
MU - Mauritius 2
PH - Filippine 2
PS - Palestinian Territory 2
RU - Federazione Russa 2
UZ - Uzbekistan 2
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ML - Mali 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 14.219
Salva come PNG Salva come JPEG
Città #
Cagliari 10.984
Uta 569
Singapore 217
Ashburn 176
Dallas 154
Fairfield 71
San Jose 61
Boardman 55
Helsinki 47
Nyköping 45
New York 42
Chandler 34
Rome 34
Los Angeles 33
Beijing 32
Woodbridge 31
Houston 30
Council Bluffs 29
Cambridge 28
Wilmington 26
Milan 25
Seoul 25
Seattle 24
Ho Chi Minh City 23
Santa Clara 23
Shanghai 23
Ann Arbor 20
Hong Kong 19
Munich 17
Hanoi 15
Hefei 15
The Dalles 15
Buffalo 13
Lauterbourg 13
Sydney 13
Chicago 11
Warsaw 11
São Paulo 10
Orem 9
Tokyo 9
Toronto 9
Turku 9
Frankfurt am Main 8
Johannesburg 8
Redondo Beach 8
Düsseldorf 7
London 7
San Diego 7
Boston 6
Haiphong 6
Heidelberg 6
Denver 5
Florence 5
Nuremberg 5
Poplar 5
Vancouver 5
Amsterdam 4
Ankara 4
Aprilia 4
Atlanta 4
Baghdad 4
Chennai 4
Dearborn 4
Dong Ket 4
Jacksonville 4
Lappeenranta 4
Manchester 4
Montreal 4
Muscat 4
Palermo 4
Riyadh 4
Roubaix 4
Vienna 4
Addis Ababa 3
Adelaide 3
Andover 3
Bangkok 3
Bexley 3
Bielefeld 3
Brooklyn 3
Brussels 3
Bắc Ninh 3
Caracas 3
Carney 3
Catania 3
Decatur 3
Draper 3
Guangzhou 3
Innsbruck 3
New Delhi 3
Philadelphia 3
Phoenix 3
Pozzilli 3
Redwood City 3
Santa Cruz 3
Sassari 3
Turin 3
Wroclaw 3
Abu Dhabi 2
Algiers 2
Totale 13.284
Salva come PNG Salva come JPEG
Nome #
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.126
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.618
Thresholds for clinical importance were defined for the EORTC CAT Core - an adaptive measure of core quality of life domains in oncology clinical practice and research 1.599
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.507
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index 1.116
Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation 792
Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials 755
Long-term health-related quality of life in patients with beta-thalassemia after unrelated hematopoietic stem cell transplantation 698
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia 685
Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021 545
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy 542
Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform 486
International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20) 478
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study 444
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura 343
Response to Dr. Ying Cui comments 293
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial 205
Health‐related quality of life and symptom profile of patients with BCR::ABL1‐negative myeloproliferative neoplasms: Real‐world evidence from the GIMEMA‐PROPHECY observational study 59
Totale 14.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.316 76 82 48 47 81 105 71 65 161 176 202 202
2022/20231.810 118 194 273 103 157 177 85 158 108 127 189 121
2023/20242.176 78 69 143 253 182 364 308 149 116 133 162 219
2024/20253.248 419 577 584 527 228 274 341 38 70 53 48 89
2025/20261.819 120 51 237 164 149 134 390 108 126 167 106 67
2026/202711 11 0 0 0 0 0 0 0 0 0 0 0
Totale 14.291